Pharma and BioTech Daily Sun, 13 Sep 2026 16:04:20 -0400 https://www.buzzsprout.com/2189790 en-us © 2026 Pharma and BioTech Daily yes Support this Podcast 02f2aba9-d55b-57fb-9481-027fb03d4963 sponsor@owith.ai Pharma and BioTech News episodic false Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech.

Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences.

Produced by OWITH.ai, a boutique AI & data studio.
Sponsor the show: https://sponsor.owith.ai

]]> Buzzsprout (https://www.buzzsprout.com) Pharma, Biotech, Podcast, News, Genomic, Artificial Intelligence Pharma and BioTech News sponsor@owith.ai https://storage.buzzsprout.com/k0uq52ujwq2dh89byq9ntc01wvqj?.jpg Pharma and BioTech Daily https://www.buzzsprout.com/2189790 FDA Expands Bayer's Hyrnuo Approval | Pharma and Biotech Daily FDA Expands Bayer's Hyrnuo Approval | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19787128 Fri, 11 Sep 2026 07:00:00 +0200 295 HER2-mutant non-small cell lung cancer, zipalertinib, tyrosine kinase inhibitor, precision medicine, mantle cell lymphoma, biologics manufacturing, CGRP receptor antagonism, NLRP3 inhibition, aseptic fill-finish capacity, gene therapy, Dravet syndrome, Al 1 767 full false Sandoz Invests $2.5B in Biosimilars Network | Pharma and Biotech Daily Sandoz Invests $2.5B in Biosimilars Network | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19781314 Thu, 10 Sep 2026 07:00:00 +0200 282 biosimilars, biologics, Imdelltra, tarlatamab-dlle, small-cell lung cancer (SCLC), bispecific T-cell engager, DLL3, FDA, Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER), monoclonal antibody therapies, ge 1 766 full false AstraZeneca's $116M FDA Win: New Breast Cancer Drug | Pharma and Biotech Daily AstraZeneca's $116M FDA Win: New Breast Cancer Drug | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19774686 Wed, 09 Sep 2026 07:00:00 +0200 306 camizestrant, ESR1 mutations, selective estrogen receptor degraders, CDK4/6 inhibitors, CAR-T cell therapy, arlocabtagene autoleucel, cefiderocol, carbapenem-resistant, deucrictibant, bradykinin B2 receptor, semaglutide, lipoprotein(a), bispecific antibod 1 765 full false FDA Approves Alzheimer's Drug: Major $ Breakthrough | Pharma and Biotech Daily FDA Approves Alzheimer's Drug: Major $ Breakthrough | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19768382 Tue, 08 Sep 2026 07:00:00 +0200 278 personalized medicine, gene-editing technology, CRISPR, genetic disorders, cystic fibrosis, sickle cell anemia, FDA accelerated approval, oncology innovation, amyloid plaques, Alzheimer's disease, universal flu vaccine, artificial intelligence drug discov 1 764 full false Ionis' Zanvastro FDA Approved: $771M Partnership Impact | Pharma and Biotech Daily Ionis' Zanvastro FDA Approved: $771M Partnership Impact | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19762890 Mon, 07 Sep 2026 07:00:00 +0200 314 Zanvastro, antisense oligonucleotide, Alexander disease, glial fibrillary acidic protein, RNA interference, GLP-1 receptor agonist, hereditary angioedema, psilocybin, MC4R-targeting drug, FDA fast track designationPharma, BioTech, News, Podcast 1 763 full false Summit & Akeso's Ivonescimab Beats Keytruda in NSCLC Phase 3 | Pharma and Biotech Daily Summit & Akeso's Ivonescimab Beats Keytruda in NSCLC Phase 3 | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19751359 Fri, 04 Sep 2026 07:00:00 +0200 326 AMT-130, gene therapy, Huntington's disease, bispecific antibody, ivonescimab, non-small cell lung cancer, biosimilar ustekinumab, IL-12/IL-23 pathways, paroxysmal supraventricular tachycardia, KRAS mutations, personalized RNA-based drug productionPharma, 1 762 full false AstraZeneca & Roche Secure EU Breast Cancer Approval | Pharma and Biotech Daily AstraZeneca & Roche Secure EU Breast Cancer Approval | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19744067 Thu, 03 Sep 2026 07:00:00 +0200 299 Enhertu, HER2-positive metastatic breast cancer, antibody-drug conjugates, ALT-B4 hyaluronidase technology, subcutaneous drug formulations, MET-overexpressing non-small cell lung cancer, personalized medicine, genomic sequencing, adeno-associated viral ce 1 761 full false Novartis' Rhapsido Hits Phase 3 Goals for MS | Pharma and Biotech Daily Novartis' Rhapsido Hits Phase 3 Goals for MS | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19738475 Wed, 02 Sep 2026 07:00:00 +0200 315 BTK inhibitor, Rhapsido, relapsing multiple sclerosis, CAR-T therapies, T-cell engager, antibody-based therapies, mRNA-based flu vaccine, PCSK9 inhibitors, TYK2 inhibitor, precision oncology, bispecific antibodiesPharma, BioTech, News, Podcast 1 760 full false Eli Lilly Acquires Merida for $2.9B | Pharma and Biotech Daily Eli Lilly Acquires Merida for $2.9B | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19732327 Tue, 01 Sep 2026 07:00:00 +0200 287 Eli Lilly, autoimmune diseases, precision degradation platform, FDA approval, polycythemia vera, hepcidin mimetic, myeloproliferative neoplasms, bispecific antibodies, RNA interference technology, neurofunction biomarkers, in vivo CAR therapies, lipid nan 1 759 full false Eli Lilly's $173M FDA Win: Mounjaro Approved! | Pharma and Biotech Daily Eli Lilly's $173M FDA Win: Mounjaro Approved! | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19725747 Mon, 31 Aug 2026 07:00:00 +0200 330 tirzepatide, dual GLP-1/GIP agonist, brepocitinib, TYK2/JAK1 inhibitor, dermatomyositis, radiopharmaceutical manufacturing, precision oncology, bictegravir/lenacapavir, integrase/capsid inhibitor, FGFR2-fusion intrahepatic cholangiocarcinoma, cardiac myos 1 758 full false Revolution Medicines' $2.25B FDA Approval Milestone | Pharma and Biotech Daily Revolution Medicines' $2.25B FDA Approval Milestone | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19713382 Fri, 28 Aug 2026 07:00:00 +0200 293 RAS inhibitor, daraxonrasib, metastatic pancreatic cancer, Tezspire, eosinophilic esophagitis, Tivicay, pediatric HIV treatment, companion diagnostics, preeclampsia, synthetic DNA, mRNA production, Ebola vaccine candidate, precision medicine, PD-1xVEGF bi 1 757 full false Revolution Medicines FDA Win: RAS Inhibitor Approved | Pharma and Biotech Daily Revolution Medicines FDA Win: RAS Inhibitor Approved | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19707740 Thu, 27 Aug 2026 07:00:00 +0200 313 ivonescimab, PD-1xVEGF bispecific antibody, non-small cell lung cancer, biliary tract cancer, FDA restructuring, drug approval processes, GLP-1 receptor agonists, KV7 ion channels, RAS inhibitor, daraxonrasib, KRAS mutations, HER2-targeted therapyPharma, 1 756 full false FDA Extends Capricor Review: $2.25B McKesson Deal | Pharma and Biotech Daily FDA Extends Capricor Review: $2.25B McKesson Deal | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19702054 Wed, 26 Aug 2026 07:00:00 +0200 314 Capricor Therapeutics, Deramiocel, Duchenne Muscular Dystrophy, monoclonal antibody, nipocalimab, antisense oligonucleotide, biosimilar pegfilgrastim, NLRP3 inhibitor, HER2 bispecific antibody, trans-amplifying RNA vaccinesPharma, BioTech, News, Podcast 1 755 full false Roche & Hanmi's $2.5B Obesity Drug Deal | Pharma and Biotech Daily Roche & Hanmi's $2.5B Obesity Drug Deal | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19695882 Tue, 25 Aug 2026 07:00:00 +0200 518 HM17321, weight loss drug, metabolic disorders, Vyepti, Rexulti, enzyme replacement therapy, Sanfilippo syndrome, trofinetide, orexin receptor agonist, tyrosine kinase inhibitor, microbiome-based medicinal productsPharma, BioTech, News, Podcast 1 754 full false Roche's $750M Genentech Expansion Boosts Biologics | Pharma and Biotech Daily Roche's $750M Genentech Expansion Boosts Biologics | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19689068 Mon, 24 Aug 2026 07:00:00 +0200 335 Genentech, fill-finish manufacturing, biologics, oncology, Complex Regional Pain Syndrome Type 1, Lupkynis, market exclusivity, ANDA approvals, small molecule development, gene therapy trials, neurological disorders, GLP-1 receptor agonistPharma, BioTech, 1 753 full false Ultragenyx's $97M Gene Therapy Breakthrough! | Pharma and Biotech Daily Ultragenyx's $97M Gene Therapy Breakthrough! | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19678231 Fri, 21 Aug 2026 07:00:00 +0200 300 gene therapy, Genglycos, Glycogen Storage Disease Type Ia, adeno-associated virus vector, monoclonal antibodies, Fibrodysplasia Ossificans Progressiva, robotic blood draw device, NICE endorsement, RNA vaccine platform, cognitive impairment schizophrenia, 1 752 full false Merck's $1B Melanoma Vaccine Breakthrough | Pharma and Biotech Daily Merck's $1B Melanoma Vaccine Breakthrough | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19672985 Thu, 20 Aug 2026 07:00:00 +0200 274 mRNA-based vaccine, melanoma trial, Keytruda, immune checkpoint inhibitors, FDA Commissioner, drug approval processes, antibody-drug conjugate, BCMA protein, multiple myeloma, gene therapy production, diabetes gene therapy, immunoglobulin products, plasma 1 751 full false Biokin's $275M ADC Success in Phase 3 Trial | Pharma and Biotech Daily Biokin's $275M ADC Success in Phase 3 Trial | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19667085 Wed, 19 Aug 2026 07:00:00 +0200 335 bispecific antibody-drug conjugate, Iza-Bren, Phase 3 trial, lung cancer, antibody-drug conjugates, oncology, immunoglobulin therapies, GLP-1 receptor antagonist, Avexitide, post-bariatric hypoglycemia, anti-dengue antibody, glioblastoma vaccinesPharma, B 1 750 full false AstraZeneca Tagrisso Breakthrough: Phase 3 Success in NSCLC | Pharma and Biotech Daily AstraZeneca Tagrisso Breakthrough: Phase 3 Success in NSCLC | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19661539 Tue, 18 Aug 2026 07:00:00 +0200 313 Trutakna, immunoglobulin A nephropathy, monoclonal antibody, EGFR-mutated non-small cell lung cancer, targeted cancer therapies, reverse merger, tau pathology, anti-CD38 antibody, ion channel research, psilocybin-based candidate, New Drug ApplicationPharm 1 749 full false FDA Fast-Tracks NASH Drug | Pharma and Biotech Daily FDA Fast-Tracks NASH Drug | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19654641 Mon, 17 Aug 2026 07:00:00 +0200 286 gene therapy, CRISPR-Cas9, rare genetic disorders, European Medicines Agency, cancer immunotherapy, checkpoint inhibitors, personalized vaccines, phase 3 trial, Alzheimer's disease, amyloid plaques, mRNA vaccine, respiratory syncytial virus (RSV), artific 1 748 full false AstraZeneca's Baxfendy Setback: Pricing Woes | Pharma and Biotech Daily AstraZeneca's Baxfendy Setback: Pricing Woes | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19643912 Fri, 14 Aug 2026 07:00:00 +0200 295 Baxfendy, Vykat XR, Prader-Willi syndrome, CAR-T cell therapy, GLP-1 weight-loss drugs, Generalized Pustular Psoriasis, EGFR inhibitor, ivonescimab, squamous NSCLC, artificial intelligence in healthcare, Fabry gene therapyPharma, BioTech, News, Podcast 1 747 full false Akeso's Ivonescimab Wins NSCLC Approval in China | Pharma and Biotech Daily Akeso's Ivonescimab Wins NSCLC Approval in China | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19639176 Thu, 13 Aug 2026 07:00:00 +0200 329 ivonescimab, non-small cell lung cancer, NSCLC, retatrutide, biosimilars, generalized anxiety disorder, ATTR stabilizer, transthyretin amyloidosis, bispecific antibody, cystinosis treatment, cystine-depleting therapy, cold chain distributionPharma, BioTec 1 746 full false Bristol Myers Squibb's $2.3B Texas Investment Boosts Jobs | Pharma and Biotech Daily Bristol Myers Squibb's $2.3B Texas Investment Boosts Jobs | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19633185 Wed, 12 Aug 2026 07:00:00 +0200 307 small molecules, biologics, antibody-drug conjugates, rare epilepsy, AKT-targeting treatment, hereditary hemorrhagic telangiectasia, IL-17A/F inhibitor, psoriatic arthritis, nanobody-based antibody, AI and machine learning technologies, gastroenteropancre 1 745 full false Novo Nordisk & AWS Partner for AI Drug Discovery Breakthrough | Pharma and Biotech Daily Novo Nordisk & AWS Partner for AI Drug Discovery Breakthrough | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19627688 Tue, 11 Aug 2026 07:00:00 +0200 313 Artificial intelligence, chronic diseases, drug discovery, RNA-based therapies, monoclonal antibody therapy, PGDx elio tissue complete CDx, BRAF-mutant advanced melanoma, CFTR modulator therapies, enzyme replacement therapy, genetic-targeted therapies, ps 1 744 full false Replimune's FDA Win: Tudriqev Approved After 2 Rejections | Pharma and Biotech Daily Replimune's FDA Win: Tudriqev Approved After 2 Rejections | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19621654 Mon, 10 Aug 2026 07:00:00 +0200 327 psychiatric drug development, psilocybin, serotonin receptors, neuroplastogens, neuroplasticity, oncolytic virus therapies, orexin receptor agonist, narcolepsy, Parkinson's disease, Alzheimer's-related aggression, regulatory approval, biopharmaceutical fr 1 743 full false Moderna mRNA Flu Vaccine Approved by FDA | Pharma and Biotech Daily Moderna mRNA Flu Vaccine Approved by FDA | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19610747 Fri, 07 Aug 2026 07:00:00 +0200 257 mRNA-based influenza vaccine, MFLUSIVA, FDA approval, orexin receptor modulation, narcolepsy type 1, biologics production, contract development and manufacturing organization, composite endpoints, Parkinson's disease clinical trials, AI in clinical trials 1 742 full false Eli Lilly's $23B Q2 Revenue Breaks Records | Pharma and Biotech Daily Eli Lilly's $23B Q2 Revenue Breaks Records | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19605360 Thu, 06 Aug 2026 07:00:00 +0200 295 Mounjaro, Zepbound, Wegovy, tenofovir-based treatments, artificial intelligence, drug discovery, precision medicine, non-small cell lung cancer, metastatic breast cancer, biologics manufacturing, rare pediatric disease priority review voucher, GBA1 gene t 1 741 full false Otsuka's Voyxact Shines in Phase 3 Trial | Pharma and Biotech Daily Otsuka's Voyxact Shines in Phase 3 Trial | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19600064 Wed, 05 Aug 2026 07:00:00 +0200 287 Voyxact, immunoglobulin A nephropathy, end-stage renal disease, monoclonal antibody, antibody-drug conjugates, precision oncology, cancer immunotherapy, MenQuadfi vaccine, polymacrocyclic peptide discovery, Investigational New Drug applications, anti-TL1A 1 740 full false Supernus & Indivior $2.2B Merger Creates CNS Giant | Pharma and Biotech Daily Supernus & Indivior $2.2B Merger Creates CNS Giant | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19594245 Tue, 04 Aug 2026 07:00:00 +0200 330 central nervous system disorders, neurological disorders, FDA approval, Pluvicto, lutetium vipivotide tetraxetan, PSMA-positive metastatic castration-resistant prostate cancer, prostate-specific membrane antigen, radioligand therapies, lurbinectedin, smal 1 739 full false Replimune's Breakthrough in Cancer Therapy | Pharma and Biotech Daily Replimune's Breakthrough in Cancer Therapy | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19588398 Mon, 03 Aug 2026 07:00:00 +0200 366 Vusolimogene Oderparepvec, advanced melanoma, gene therapy, oncolytic virus, PD-1 checkpoint inhibitors, antibody-drug conjugates, Trop-2 protein, monoclonal antibody, autoimmune diseases, JAK3 inhibitor, atherosclerotic cardiovascular disease, GLP-1 rece 1 738 full false Johnson & Johnson's $785M CAR-T Deal & More | Pharma and Biotech Daily Johnson & Johnson's $785M CAR-T Deal & More | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19577413 Fri, 31 Jul 2026 07:00:00 +0200 349 in vivo CAR-T cell therapy, autoimmune diseases, monoclonal antibody, Dupixent, IBAT inhibitor, primary biliary cholangitis, IL-15 cytokine-based protein therapy, nanoparticle therapy, AI-powered drug discovery, Alzheimer's psychosis treatment, ATTR franc 1 737 full false Biogen Acquires Apellis for Growth | Pharma and Biotech Daily Biogen Acquires Apellis for Growth | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19571939 Thu, 30 Jul 2026 07:00:00 +0200 300 Biogen, Apellis Pharmaceuticals, Rinvoq, upadacitinib, JAK inhibitor, trastuzumab deruxtecan, HER2-positive breast cancer, CAR-T therapy, autoimmune T-cell engagement, artificial intelligence in drug development, PMN310, amyloid-beta oligomersPharma, BioT 1 736 full false GlaxoSmithKline's $2.5B Restructuring Near AstraZeneca | Pharma and Biotech Daily GlaxoSmithKline's $2.5B Restructuring Near AstraZeneca | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19565940 Wed, 29 Jul 2026 07:00:00 +0200 302 GlaxoSmithKline, late-stage research, Johnson & Johnson, talc litigation, FDA approval, edema autoinjector, cefazolin recall, B7-H3 antibody-drug conjugate, Phase 3 trial, GLP-1/glucagon receptor, alcohol use disorder, intellectual property risksPharma, B 1 735 full false AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19558953 Tue, 28 Jul 2026 07:00:00 +0200 271 AstraZeneca, antibody-drug conjugates, Duchenne Muscular Dystrophy, norepinephrine dopamine serotonin reuptake inhibitor, central nervous system therapeutics, wet age-related macular degeneration, biologics, TYK2 inhibitor, colorectal cancer screening, CA 1 734 full false Scribe Therapeutics Raises $129M in IPO | Pharma and Biotech Daily Scribe Therapeutics Raises $129M in IPO | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19552436 Mon, 27 Jul 2026 07:00:00 +0200 320 gene editing, CRISPR technology, cardiovascular diseases, atherosclerotic cardiovascular disease, FDA approval, peptides therapeutic potential, epigenetic immunomodulator, PD-1 inhibitor, oncology therapeutics, progression-free survival endpoint, atopic d 1 733 full false Eli Lilly's Retatrutide: 22.6% Weight Loss in Phase 3! | Pharma and Biotech Daily Eli Lilly's Retatrutide: 22.6% Weight Loss in Phase 3! | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19540568 Fri, 24 Jul 2026 07:00:00 +0200 274 retatrutide, GLP-1 receptor agonist, Phase 3 trials, cardiovascular disease, multiple myeloma, bispecific antibody, BCMA, GPRC5D, ROS1-positive metastatic non-small cell lung cancer, kinase inhibitor, FDA Modernization Act 3.0, ox2r agonist, narcolepsy ty 1 732 full false Repligen Buys BioLife for $1.5B | Pharma and Biotech Daily Repligen Buys BioLife for $1.5B | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19534727 Thu, 23 Jul 2026 07:00:00 +0200 306 cryopreservation media, cell viability, regenerative medicine, radioligand therapy, uric acid levels, MHRA approval, low-carbon propellant, interferon alpha-2b, small molecule therapeutics, AI-driven drug discovery, triglyceride-lowering drug, FDA approva 1 731 full false Bristol Myers & NVIDIA's $1.5B AI Deal: Game Changer? | Pharma and Biotech Daily Bristol Myers & NVIDIA's $1.5B AI Deal: Game Changer? | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19528564 Wed, 22 Jul 2026 07:00:00 +0200 292 AI infrastructure, drug discovery, predictive modeling, HIV treatment, islatravir, lenacapavir, oncology diagnostics, minimal residual disease, precision oncology, dengue vaccine, Qdenga, enzyme replacement therapy, rare genetic disorders, Enhaze technolo 1 730 full false Samsung Biologics' $1.8B Peptide Expansion | Pharma and Biotech Daily Samsung Biologics' $1.8B Peptide Expansion | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19521792 Tue, 21 Jul 2026 07:00:00 +0200 336 peptide production, metabolic disorders, psychedelics, genomics-driven insights, precision medicine, AI supercomputer, drug discovery, Qdenga dengue vaccine, gene therapy, Nav1.8 inhibitor, CRISPR technology, lipid-lowering therapiesPharma, BioTech, News, 1 729 full false Jasper Merges with Kira for $292M | Pharma and Biotech Daily Jasper Merges with Kira for $292M | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19515969 Mon, 20 Jul 2026 07:00:00 +0200 319 autoimmune therapeutics, KP-104, TYK2 inhibitor, IL-23 pathway, Fabhalta, Iptacopan, primary immunoglobulin A nephropathy, small molecule complement inhibitor, acute kidney injuries, artificial intelligence drug discovery, protein engineering, biologics m 1 728 full false Merck's $5B Lipfendra FDA Approval Revolutionizes Cholesterol | Pharma and Biotech Daily Merck's $5B Lipfendra FDA Approval Revolutionizes Cholesterol | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19504992 Fri, 17 Jul 2026 07:00:00 +0200 286 PCSK9 inhibitor, hypercholesterolemia, psychedelic therapeutics, GLP-1 receptor agonist, semaglutide, PD-1 inhibitor, mismatch repair-deficient endometrial cancer, IL-23 inhibitor, BRCA1/2-mutated metastatic prostate cancer, TYK2 inhibitor, nonsegmental v 1 727 full false Veradermics' $2B Hair Loss Market Move with Oral Minoxidil | Pharma and Biotech Daily Veradermics' $2B Hair Loss Market Move with Oral Minoxidil | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19500036 Thu, 16 Jul 2026 07:00:00 +0200 348 minoxidil, female pattern hair loss, clinical trial, patent protection, small molecule inhibitor, FDA approval, non-small cell lung cancer, amyloid protein, tau protein, gene therapy, regulatory landscapes, antisense drugPharma, BioTech, News, Podcast 1 726 full false Biogen's $1.5B Deal & FDA Approval for Alzheimer's Drug | Pharma and Biotech Daily Biogen's $1.5B Deal & FDA Approval for Alzheimer's Drug | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19494612 Wed, 15 Jul 2026 07:00:00 +0200 275 diranersen, antisense oligonucleotide, tau protein, Alzheimer's disease, Leqembi, amyloid-beta plaques, BRAF V600E-mutant metastatic colorectal cancer, precision medicine, AI-driven therapeutic antibody discovery, T-cell engager, ADC drug discovery, combi 1 725 full false Pfizer & Merck's $3B Bladder Cancer Breakthrough | Pharma and Biotech Daily Pfizer & Merck's $3B Bladder Cancer Breakthrough | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19489043 Tue, 14 Jul 2026 07:00:00 +0200 297 Padcev, Keytruda, muscle-invasive bladder cancer, antibody-drug conjugate, PD-1 inhibitor, diffuse large B-cell lymphoma, bispecific antibodies, erythropoietic protoporphyria, melanocortin receptor agonist, CNS drug discovery, tau tangle biomarkers, domin 1 724 full false Sanofi's FDA Approval: $160M Boost for Sarclisa in Cancer Care | Pharma and Biotech Daily Sanofi's FDA Approval: $160M Boost for Sarclisa in Cancer Care | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19483028 Mon, 13 Jul 2026 07:00:00 +0200 316 Sarclisa Escena, isatuximab, CD38, multiple myeloma, antibody-drug conjugate, B7-H3, small cell lung cancer, IL-15 pathway, personalized genetic medicines, ARPA-H, gene therapy, AI-driven drug discovery, HER2 antibody-drug conjugate, mRNA vaccine, regulat 1 723 full false Ipsen's Dysport Hits Phase 3 Milestone vs. Botox | Pharma and Biotech Daily Ipsen's Dysport Hits Phase 3 Milestone vs. Botox | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19471656 Fri, 10 Jul 2026 07:00:00 +0200 313 Dysport, botulinum toxin-based therapies, neurotoxin market, PDE4B inhibitor, idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, FAK inhibitors, CAR-T therapy, GLP-1 obesity pill, pyruvate dehydrogenase complex deficiency, KRAS G12C inhibitor, 1 722 full false Vera Therapeutics' Trutakna Gets FDA Nod for IgA Nephropathy | Pharma and Biotech Daily Vera Therapeutics' Trutakna Gets FDA Nod for IgA Nephropathy | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19465908 Thu, 09 Jul 2026 07:00:00 +0200 274 FDA accelerated approval, IgA nephropathy, APRIL and BAFF pathways, nephrology therapeutics, fusion proteins, COPD candidate TQC3721, AAK1 inhibitor, Duchenne muscular dystrophy, Contract Development and Manufacturing Organization (CDMO), gene therapies, 1 721 full false Vertex Acquires Crinetics for $10B | Pharma and Biotech Daily Vertex Acquires Crinetics for $10B | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19460337 Wed, 08 Jul 2026 07:00:00 +0200 285 Vertex Pharmaceuticals, Crinetics Pharmaceuticals, endocrine disease, cystic fibrosis, melanocortin system, obesity, cancer cachexia, psilocybin-based therapy, treatment-resistant depression, bispecific antibodies, follicular lymphoma, polycythemia vera, 1 720 full false Novartis' $1.1B Myricx Acquisition Boosts ADC Pipeline | Pharma and Biotech Daily Novartis' $1.1B Myricx Acquisition Boosts ADC Pipeline | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19454540 Tue, 07 Jul 2026 07:00:00 +0200 312 biosimilars, gene therapy, Casgevy, sickle cell disease, antibody-drug conjugate, NMT inhibitor, precision oncology, regulatory landscape, CRISPR-based gene editing, Idiopathic Pulmonary Fibrosis, Metabolic-Associated Steatohepatitis, transthyretin amyloi 1 719 full false FDA Accelerated Approval: New Drug for Breast Cancer | Pharma and Biotech Daily FDA Accelerated Approval: New Drug for Breast Cancer | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19448353 Mon, 06 Jul 2026 07:00:00 +0200 283 gene therapy, Leber congenital amaurosis, RPE65 gene, adeno-associated virus vector, accelerated approval, triple-negative breast cancer, kinase inhibitor, European Medicines Agency, monoclonal antibody, anti-amyloid antibody, amyloid hypothesis, mRNA tec 1 718 full false Roche's Divarasib Surpasses Amgen in Trials | Pharma and Biotech Daily Roche's Divarasib Surpasses Amgen in Trials | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19438129 Fri, 03 Jul 2026 07:00:00 +0200 326 Divarasib, KRAS G12C-mutated, non-small cell lung cancer, precision medicine, CRISPR technology, gene therapy, exagamglogene autotemcel, RNA therapeutics, AI-driven drug discovery, antibody-drug conjugates, Wnt/β-catenin signaling pathways, immunoglobulin 1 717 full false Orca Bio's Tregzi Wins FDA Approval for GVHD | Pharma and Biotech Daily Orca Bio's Tregzi Wins FDA Approval for GVHD | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19432829 Thu, 02 Jul 2026 07:00:00 +0200 327 cell therapy, graft-versus-host disease, regulatory T cells, monoclonal antibodies, BK virus, personalized medicine, artificial intelligence in drug discovery, miR-124 enhancer, biosimilar pipeline, exon skipping technology, Duchenne muscular dystrophy, C 1 716 full false FDA Fast-Tracks Eli Lilly & Regeneron | Pharma and Biotech Daily FDA Fast-Tracks Eli Lilly & Regeneron | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19427019 Wed, 01 Jul 2026 07:00:00 +0200 281 U.S. Food and Drug Administration, PreCheck pilot program, Eli Lilly, Regeneron, zanubrutinib, mantle cell lymphoma, trispecific T-cell engager, autoimmune diseases, precision medicine, enzyme replacement therapy, GAA enzyme deficiency, CAR-T therapy, dif 1 715 full false Ipsen Buys Kartos for $1.75B | Pharma and Biotech Daily Ipsen Buys Kartos for $1.75B | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19420646 Tue, 30 Jun 2026 07:00:00 +0200 324 navtemadlin, MDM2 inhibitor, myelofibrosis, hematologic oncology, Lumvoa, IGF-1R monoclonal antibody, trastuzumab deruxtecan, antibody-drug conjugate, efzimfotase alfa, hypophosphatasia, fibroblast growth factor receptor inhibitor, bispecific antibodies, 1 714 full false Replimune's RP1 Resubmission to FDA: Will It Finally Pass? | Pharma and Biotech Daily Replimune's RP1 Resubmission to FDA: Will It Finally Pass? | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19414388 Mon, 29 Jun 2026 07:00:00 +0200 311 RP1, oncolytic virus, advanced melanoma, FDA approval, PD-1 inhibitor, gene therapy, epigenetic silencing, FGFR2/3 inhibitors, antibody-drug conjugate, mRNA vaccines, RAS blockerPharma, BioTech, News, Podcast 1 713 full false Merck's $11.3B Bio-Techne Acquisition | Pharma and Biotech Daily Merck's $11.3B Bio-Techne Acquisition | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19403813 Fri, 26 Jun 2026 07:00:00 +0200 292 Merck KGaA acquisition, antibody-drug conjugate, triple-negative breast cancer, PD-1 inhibitor, CDK4/6 inhibitor, antisense oligonucleotide therapies, apolipoprotein C-III, artificial intelligence in drug discovery, T-cell target discovery, small molecule 1 712 full false Eli Lilly's $1.9B Abbisko Partnership Boosts Cancer R&D | Pharma and Biotech Daily Eli Lilly's $1.9B Abbisko Partnership Boosts Cancer R&D | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19398054 Thu, 25 Jun 2026 07:00:00 +0200 308 PD-1 inhibitor, non-small cell lung cancer, Eli Lilly, Abbisko Therapeutics, antibody-drug conjugate, JAK inhibitor Opzelura, radiopharmaceutical production, small molecule development, precision medicine, blood-based diagnostic tests, gene editing techno 1 711 full false Carsgen's $2T Satricabtagene Approval Milestone | Pharma and Biotech Daily Carsgen's $2T Satricabtagene Approval Milestone | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19392417 Wed, 24 Jun 2026 07:00:00 +0200 314 satricabtagene autoleucel, Claudin18.2-positive, advanced gastric adenocarcinoma, tolebrutinib, BTK inhibitor, BRAF V600E-mutant, sacituzumab govitecan, IL-23 inhibitor, tirzepatide, GLP-1 receptor agonist, antibody-drug conjugates, precision medicinePhar 1 710 full false Carsgen's CAR-T Breakthrough in China for Solid Tumors | Pharma and Biotech Daily Carsgen's CAR-T Breakthrough in China for Solid Tumors | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19386366 Tue, 23 Jun 2026 07:00:00 +0200 279 CAR-T therapy, Claudin18.2, hematologic malignancies, drug spending reforms, pharmaceutical pricing, mRNA capabilities, FDA advisory committee, influenza vaccine, LSD-based treatment, psychedelic therapeutics, AI-driven drug discovery, neuroimmune disorde 1 709 full false FDA Approves Alzheimer's Drug Amid Debate | Pharma and Biotech Daily FDA Approves Alzheimer's Drug Amid Debate | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19379768 Mon, 22 Jun 2026 07:00:00 +0200 254 gene therapy, CRISPR technology, genetic disorder, FDA accelerated approval, Alzheimer's drug, amyloid plaques, cognitive decline, mRNA-based vaccine, respiratory syncytial virus, CAR-T cell therapy, tumor microenvironments, personalized medicine, genomic 1 708 full false FDA Approves Utebzi, Biogen Acquires Raythera for $1B | Pharma and Biotech Daily FDA Approves Utebzi, Biogen Acquires Raythera for $1B | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19368816 Fri, 19 Jun 2026 07:00:00 +0200 291 minimal residual disease, tumor-informed MRD, precision oncology, avutometinib, defactinib, glioblastoma, FDA approval, biosimilar, GLP-1 drug, multispecific antibodies, invasive aspergillosis, metabolic dysfunction-associated steatohepatitisPharma, BioTe 1 707 full false Eli Lilly's $65B M&A Surge & FDA's Drug Import Approval | Pharma and Biotech Daily Eli Lilly's $65B M&A Surge & FDA's Drug Import Approval | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19363368 Thu, 18 Jun 2026 07:00:00 +0200 319 mRNA technology, precision medicine, non-opioid pain management, Biologics License Application, Huntington's disease therapy, T-cell-engaging antibodies, regulatory approval, gene therapy, precision oncology, drug discovery processesPharma, BioTech, News, 1 706 full false Intellia's 89% Success in Phase 3 CRISPR Trial | Pharma and Biotech Daily Intellia's 89% Success in Phase 3 CRISPR Trial | Pharma and Biotech Daily Support the show

]]> Support the show

]]> Pharma Daily Buzzsprout-19357340 Wed, 17 Jun 2026 07:00:00 +0200 234 lonvoguran ziclumeran, hereditary angioedema, CRISPR technology, antisense oligonucleotides, gene therapy, biologic drug manufacturing, monoclonal antibody production, AI/ML technology, protein design platform, ulcerative colitis, anti-TL1A, hypertrophic 1 705 full false